Published in Angew Chem Int Ed Engl on January 01, 2007
Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv Drug Deliv Rev (2009) 3.17
Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities. Science (2012) 2.73
Imaging and drug delivery using theranostic nanoparticles. Adv Drug Deliv Rev (2010) 2.37
Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy. Theranostics (2012) 2.35
Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy. Int J Nanomedicine (2008) 2.20
Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress. Int J Nanomedicine (2010) 1.55
Doxorubicin loaded iron oxide nanoparticles overcome multidrug resistance in cancer in vitro. J Control Release (2011) 1.36
Theranostic nanoplatforms for simultaneous cancer imaging and therapy: current approaches and future perspectives. Nanoscale (2011) 1.25
Theranostic applications of nanomaterials in cancer: drug delivery, image-guided therapy, and multifunctional platforms. Appl Biochem Biotechnol (2011) 1.22
Hybrid nanoparticles for detection and treatment of cancer. Adv Mater (2012) 1.16
Receptor-targeted nanocarriers for therapeutic delivery to cancer. Mol Membr Biol (2010) 1.11
Revisiting an old friend: manganese-based MRI contrast agents. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2010) 1.09
Bioinspired Surface Immobilization of Hyaluronic Acid on Monodisperse Magnetite Nanocrystals for Targeted Cancer Imaging. Adv Mater (2008) 1.09
Magnetic nanoparticles for cancer diagnosis and therapy. Pharm Res (2012) 1.03
In vitro evaluation of novel polymer-coated magnetic nanoparticles for controlled drug delivery. Nanomedicine (2010) 1.02
Nanomedicine strategies for molecular targets with MRI and optical imaging. Future Med Chem (2010) 0.99
Oh the irony: Iron as a cancer cause or cure? Biomaterials (2011) 0.98
Nanoparticle-based theragnostics: Integrating diagnostic and therapeutic potentials in nanomedicine. J Control Release (2010) 0.92
Synthesis, characterization, and in vitro evaluation of novel polymer-coated magnetic nanoparticles for controlled delivery of doxorubicin. Nanotechnol Sci Appl (2012) 0.91
Multifunctional surface modification of gold-stabilized nanoparticles by bioorthogonal reactions. J Am Chem Soc (2011) 0.90
Cancer immunotherapy: nanodelivery approaches for immune cell targeting and tracking. Front Chem (2014) 0.89
Synthesis, characterization and in vitro studies of doxorubicin-loaded magnetic nanoparticles grafted to smart copolymers on A549 lung cancer cell line. J Nanobiotechnology (2012) 0.88
Delivery of cancer therapeutics using nanotechnology. Pharmaceutics (2013) 0.88
Nanogel Carrier Design for Targeted Drug Delivery. J Mater Chem B Mater Biol Med (2014) 0.83
Current advances in polymer-based nanotheranostics for cancer treatment and diagnosis. ACS Appl Mater Interfaces (2014) 0.81
Fabrication of magnetic nanoparticles with controllable drug loading and release through a simple assembly approach. J Control Release (2012) 0.81
Investigating the parameters affecting the stability of superparamagnetic iron oxide-loaded nanoemulsion using artificial neural networks. AAPS PharmSciTech (2012) 0.80
Doxorubicin-modified magnetic nanoparticles as a drug delivery system for magnetic resonance imaging-monitoring magnet-enhancing tumor chemotherapy. Int J Nanomedicine (2016) 0.80
Use of Nanotechnology to Develop Multi-Drug Inhibitors For Cancer Therapy. J Nanomed Nanotechnol (2013) 0.80
Physically facilitating drug-delivery systems. Ther Deliv (2012) 0.79
Tailoring nanoparticle designs to target cancer based on tumor pathophysiology. Proc Natl Acad Sci U S A (2016) 0.78
In vivo anticancer evaluation of the hyperthermic efficacy of anti-human epidermal growth factor receptor-targeted PEG-based nanocarrier containing magnetic nanoparticles. Int J Nanomedicine (2014) 0.78
Nanomechanical in situ monitoring of proteolysis of peptide by Cathepsin B. PLoS One (2009) 0.76
Targeting multiple types of tumors using NKG2D-coated iron oxide nanoparticles. Nanotechnology (2014) 0.75
Dual-functional lipid-like nanoparticles for delivery of mRNA and MRI contrast agents. Nanoscale (2017) 0.75
Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat Med (2006) 7.05
Nanoscale size effect of magnetic nanocrystals and their utilization for cancer diagnosis via magnetic resonance imaging. J Am Chem Soc (2005) 3.67
In vivo magnetic resonance detection of cancer by using multifunctional magnetic nanocrystals. J Am Chem Soc (2005) 2.83
Surface modulation of magnetic nanocrystals in the development of highly efficient magnetic resonance probes for intracellular labeling. J Am Chem Soc (2005) 2.25
Overcoming artifacts from metallic orthopedic implants at high-field-strength MR imaging and multi-detector CT. Radiographics (2007) 2.08
Scoliosis imaging: what radiologists should know. Radiographics (2010) 1.77
Nanomaterials for theranostics: recent advances and future challenges. Chem Rev (2014) 1.75
Involvement of histone methylation and phosphorylation in regulation of transcription by thyroid hormone receptor. Mol Cell Biol (2002) 1.63
Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation. Cancer Res (2009) 1.48
Isolation and characterization of a novel lipase from a metagenomic library of tidal flat sediments: evidence for a new family of bacterial lipases. Appl Environ Microbiol (2006) 1.46
Identification and functional analysis of the fusaricidin biosynthetic gene of Paenibacillus polymyxa E681. Biochem Biophys Res Commun (2007) 1.45
Reversible SUMOylation of TBL1-TBLR1 regulates β-catenin-mediated Wnt signaling. Mol Cell (2011) 1.45
Grape seed extract regulates androgen receptor-mediated transcription in prostate cancer cells through potent anti-histone acetyltransferase activity. J Med Food (2011) 1.43
Extraaxial neurofibromas versus neurilemmomas: discrimination with MRI. AJR Am J Roentgenol (2004) 1.40
Novel Polydioxanone Multifilament Scaffold Device for Tissue Regeneration. Dermatol Surg (2016) 1.38
Proto-oncogene FBI-1 (Pokemon/ZBTB7A) represses transcription of the tumor suppressor Rb gene via binding competition with Sp1 and recruitment of co-repressors. J Biol Chem (2008) 1.36
Identification of a polymyxin synthetase gene cluster of Paenibacillus polymyxa and heterologous expression of the gene in Bacillus subtilis. J Bacteriol (2009) 1.33
Implantation of human umbilical cord-derived mesenchymal stem cells as a neuroprotective therapy for ischemic stroke in rats. Brain Res (2008) 1.30
Proteolytic cleavage of extracellular secreted {alpha}-synuclein via matrix metalloproteinases. J Biol Chem (2005) 1.25
Multifunctional nanoparticles for combined doxorubicin and photothermal treatments. ACS Nano (2009) 1.21
Metal artefact reduction in gemstone spectral imaging dual-energy CT with and without metal artefact reduction software. Eur Radiol (2012) 1.20
Regulation of P-TEFb elongation complex activity by CDK9 acetylation. Mol Cell Biol (2007) 1.13
Antiviral activity of quercetin 7-rhamnoside against porcine epidemic diarrhea virus. Antiviral Res (2008) 1.12
Accuracy of fluorodeoxyglucose-positron emission tomography for diagnosis of single bone metastasis: comparison with bone scintigraphy. J Comput Assist Tomogr (2007) 1.12
Signal pathway of 17beta-estradiol-induced MUC5B expression in human airway epithelial cells. Am J Respir Cell Mol Biol (2008) 1.11
Gallic acid suppresses lipopolysaccharide-induced nuclear factor-kappaB signaling by preventing RelA acetylation in A549 lung cancer cells. Mol Cancer Res (2009) 1.10
Size-dependent magnetic properties of colloidal Mn(3)O(4) and MnO nanoparticles. Angew Chem Int Ed Engl (2004) 1.09
Nanoparticle-enabled terahertz imaging for cancer diagnosis. Opt Express (2009) 1.09
Prostate cancer cell death produced by the co-delivery of Bcl-xL shRNA and doxorubicin using an aptamer-conjugated polyplex. Biomaterials (2010) 1.07
Hollow silica nanocontainers as drug delivery vehicles. Langmuir (2008) 1.05
A role of the amino-terminal (N) and carboxyl-terminal (C) interaction in binding of androgen receptor to chromatin. Mol Endocrinol (2005) 1.05
Rengyolone inhibits inducible nitric oxide synthase expression and nitric oxide production by down-regulation of NF-kappaB and p38 MAP kinase activity in LPS-stimulated RAW 264.7 cells. Biochem Pharmacol (2006) 1.03
TGF-β1-induced epithelial-mesenchymal transition and acetylation of Smad2 and Smad3 are negatively regulated by EGCG in human A549 lung cancer cells. Cancer Lett (2013) 1.02
HDAC3 selectively represses CREB3-mediated transcription and migration of metastatic breast cancer cells. Cell Mol Life Sci (2010) 1.02
Hyaluronan-modified magnetic nanoclusters for detection of CD44-overexpressing breast cancer by MR imaging. Biomaterials (2011) 1.02
Role of magnetic resonance imaging in entrapment and compressive neuropathy--what, where, and how to see the peripheral nerves on the musculoskeletal magnetic resonance image: part 2. Upper extremity. Eur Radiol (2006) 1.01
Intrinsic ligament and triangular fibrocartilage complex (TFCC) tears of the wrist: comparison of isovolumetric 3D-THRIVE sequence MR arthrography and conventional MR image at 3 T. Magn Reson Imaging (2012) 1.01
Chronic tibiofibular syndesmosis injury: the diagnostic efficiency of magnetic resonance imaging and comparative analysis of operative treatment. Foot Ankle Int (2007) 1.00
p53 regulates nuclear GSK-3 levels through miR-34-mediated Axin2 suppression in colorectal cancer cells. Cell Cycle (2013) 1.00
In vivo MR imaging of tissue-engineered human mesenchymal stem cells transplanted to mouse: a preliminary study. Ann Biomed Eng (2006) 1.00
Intravascular papillary endothelial hyperplasia of the extremities: MR imaging findings with pathologic correlation. Eur Radiol (2003) 0.98
Multifunctional nanoparticles for photothermally controlled drug delivery and magnetic resonance imaging enhancement. Small (2008) 0.98
pH-triggered drug-releasing magnetic nanoparticles for cancer therapy guided by molecular imaging by MRI. Adv Mater (2011) 0.98
MRI of chondromyxoid fibroma. Acta Radiol (2011) 0.97
Chronic tibiofibular syndesmosis injury of ankle: evaluation with contrast-enhanced fat-suppressed 3D fast spoiled gradient-recalled acquisition in the steady state MR imaging. Radiology (2007) 0.97
Convertible organic nanoparticles for near-infrared photothermal ablation of cancer cells. Angew Chem Int Ed Engl (2011) 0.96
The role of popliteal lymph nodes in differentiating rheumatoid arthritis from osteoarthritis by using CE 3D FSPGR MR imaging: relationship of the inflamed synovial volume. Korean J Radiol (2005) 0.95
Usefulness of slice encoding for metal artifact correction (SEMAC) for reducing metallic artifacts in 3-T MRI. Magn Reson Imaging (2013) 0.94
Isolation of glioma cancer stem cells in relation to histological grades in glioma specimens. Childs Nerv Syst (2012) 0.94
Molecular imaging with terahertz waves. Opt Express (2011) 0.93
Magnetic poly epsilon-caprolactone nanoparticles containing Fe3O4 and gemcitabine enhance anti-tumor effect in pancreatic cancer xenograft mouse model. J Drug Target (2007) 0.93
Fluorescent magnetic nanohybrids as multimodal imaging agents for human epithelial cancer detection. Biomaterials (2008) 0.92
Quantitative computed tomography (QCT) as a radiology reporting tool by using optical character recognition (OCR) and macro program. J Digit Imaging (2012) 0.92
Efficacy of multidetector row computed tomography of the spine in patients with multiple myeloma: comparison with magnetic resonance imaging and fluorodeoxyglucose-positron emission tomography. J Comput Assist Tomogr (2007) 0.92
Gallic acid, a histone acetyltransferase inhibitor, suppresses β-amyloid neurotoxicity by inhibiting microglial-mediated neuroinflammation. Mol Nutr Food Res (2011) 0.91
Targetable gold nanorods for epithelial cancer therapy guided by near-IR absorption imaging. Small (2012) 0.91
In vitro and in vivo hepatoprotective effects of the aqueous extract from Taraxacum officinale (dandelion) root against alcohol-induced oxidative stress. Food Chem Toxicol (2010) 0.91
Phthalocyanine tetrasulfonates affect the amyloid formation and cytotoxicity of alpha-synuclein. Biochemistry (2004) 0.91
Preparation of poly epsilon-caprolactone nanoparticles containing magnetite for magnetic drug carrier. Int J Pharm (2006) 0.91
Active targeting and safety profile of PEG-modified adenovirus conjugated with herceptin. Biomaterials (2011) 0.91